Reportlinker Adds Biogen Idec Inc.: PharmaVitae Profile

Dec 08, 2010, 09:50 ET from Reportlinker

NEW YORK, Dec. 8, 2010 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Biogen Idec Inc.: PharmaVitae Profile


This analysis examines the historical and forecast performance for Biogen Idec in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits

Gain insight into Biogen Idec's strategic outlook across the next 6 years

Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source


Strategic insight into the prospects for Biogen Idec over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Your key questions answered

Benchmark Biogen Idec's performance against key rivals in the prescription pharmaceutical sector

See how the launch of company's multiple sclerosis portfolio is in transition as oral treatments become available

To order this report:

: Biogen Idec Inc.: PharmaVitae Profile

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!


Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker